Figures & data
Table 1 List of studies included in Category 1
Table 2 List of studies included in Category 2
Figure 1 Selection of articles outlined according to PRISMA guidelines.
Abbreviations: IOP, intraocular pressure; NTG, normal-tension glaucoma; PGA, prostaglandin analogs.
![Figure 1 Selection of articles outlined according to PRISMA guidelines.](/cms/asset/649becaf-ac1c-426c-a996-a988006176c4/doph_a_166657_f0001_b.jpg)
Figure 2 Weighted ocular hypotensive efficacy of prostaglandin analogs calculated using data from the studies in Category 1.
![Figure 2 Weighted ocular hypotensive efficacy of prostaglandin analogs calculated using data from the studies in Category 1.](/cms/asset/89dedfcc-f73f-439e-99f6-05bfbfe443e1/doph_a_166657_f0002_b.jpg)
Figure 3 Scatter plot analysis of studies in Category 2 as a function of predosing IOP values.
![Figure 3 Scatter plot analysis of studies in Category 2 as a function of predosing IOP values.](/cms/asset/69709f15-6abc-4fa3-b75c-3036636eefa3/doph_a_166657_f0003_c.jpg)
Figure 4 Scatter plot analysis of studies in Category 2 as a function of (A) IOP reduction and (B) percentage IOP reduction.
![Figure 4 Scatter plot analysis of studies in Category 2 as a function of (A) IOP reduction and (B) percentage IOP reduction.](/cms/asset/f6ad72d6-48af-4419-a9e8-6c2b85ccae18/doph_a_166657_f0004_c.jpg)